AUTHOR=Domondon Mark , Polina Iuliia , Nikiforova Anna B. , Sultanova Regina F. , Kruger Claudia , Vasileva Valeriia Y. , Fomin Mikhail V. , Beeson Gyda C. , Nieminen Anna-Liisa , Smythe Nancy , Maldonado Eduardo N. , Stadler Krisztian , Ilatovskaya Daria V. 

TITLE=Renal Glomerular Mitochondria Function in Salt-Sensitive Hypertension

JOURNAL=Frontiers in Physiology

VOLUME=Volume 10 - 2019

YEAR=2020

URL=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.01588

DOI=10.3389/fphys.2019.01588

ISSN=1664-042X

ABSTRACT=Salt-sensitive (SS) hypertension is accompanied with an early onset of proteinuria, which results from the loss of glomerular podocytes. Here, we hypothesized that glomerular damage in the SS hypertension occurs in part due to mitochondria dysfunction, and used a unique model of freshly isolated glomeruli to test this hypothesis. In order to mimic SS hypertension, we used Dahl SS rats, an established animal model. Animals fed a 0.4% NaCl (normal salt, NS) diet were challenged with a high salt (HS) 4% NaCl diet for 21 days to induce an increase in blood pressure. Similar to previous studies, we found that HS diet caused renal hypertrophy, increased blood pressure, glomerulosclerosis, and renal lesions such as fibrosis and protein casts. We did not observe changes in mitochondria biogenesis in the renal cortex or isolated glomeruli fractions. However, Seahorse assays performed on freshly isolated glomeruli revealed that basal mitochondrial respiration, maximal respiration and spare respiratory capacity were lower in the HS compared to NS group. Using confocal imaging and staining for mitochondrial H2O2 using mitoPY1, we detected an intensified response to an acute H2O2 application in the podocytes of the glomeruli isolated from HS diet fed group. TEM analysis showed that glomerular mitochondria from HS diet fed group have structural abnormalities (swelling, enlargement, less defined cristae). Therefore, we report that glomerular mitochondria in SS hypertension are functionally and structurally defective, and this impairment could eventually lead to loss of podocytes and proteinuria. Thus, the glomerular-mitochondria axis can be targeted in novel treatment strategies for hypertensive glomerulosclerosis.